References
Bauer H, Zweimueller-Mayer J, Steinbacher P, Lametschwandtner A, Bauer HC (2010) The dual role of zonula occludens (ZO) proteins. J Biomed Biotechnol 2010:402593 (review)
Becquet D, Francois-Bellan AM, Boudouresque F, Faudon M, Hery F, Guillaume V, Hery M (1990) Serotonin synthesis from tryptophan by hypothalamic cells in serum-free medium culture. Brain Res Dev Brain Res 54(1):142–146
Bengoetxea H, Argandoña EG, Lafuente JV (2008) Effects of visual experience on vascular endothelial growth factor expression during the postnatal development of the rat visual cortex. Cereb Cortex 18(7):1630–1639
Bonda DJ, Lee HP, Lee HG, Friedlich AL, Perry G, Zhu X, Smith MA (2010) Novel therapeutics for Alzheimer’s disease: an update. Curr Opin Drug Discov Devel 13(2):235–246 (review)
Bondioli L, Costantino L, Ballestrazzi A, Lucchesi D, Boraschi D, Pellati F, Benvenuti S, Tosi G, Vandelli MA (2010) PLGA nanoparticles surface decorated with the sialic acid, N-acetylneuraminic acid. Biomaterials 31(12):3395–3403
Brightman MW, Reese TS (1969) Junctions between intimately apposed cell membranes in the vertebrate brain. J Cell Biol 40(3):648–677
Brightman MW, Klatzo I, Olsson Y, Reese TS (1970) The blood-brain barrier to proteins under normal and pathological conditions. J Neurol Sci 10(3):215–239 (review)
Castellani RJ, Rolston RK, Smith MA (2010) Alzheimer disease. Dis Mon 56(9):484–546 (review)
Gustaw-Rothenberg K, Lerner A, Bonda DJ, Lee HG, Zhu X, Perry G, Smith MA (2010) Biomarkers in Alzheimer’s disease: past, present and future. Biomark Med 4(1):15–26 (review)
Johanson CE, Stopa EG, McMillan PN (2011) The blood-cerebrospinal fluid barrier: structure and functional significance. Methods Mol Biol 686:101–131
Li Y, Perry T, Kindy MS, Harvey BK, Tweedie D, Holloway HW, Powers K, Shen H, Egan JM, Sambamurti K, Brossi A, Lahiri DK, Mattson MP, Hoffer BJ, Wang Y, Greig NH (2009) GLP-1 receptor stimulation preserves primary cortical and dopaminergic neurons in cellular and rodent models of stroke and Parkinsonism. Proc Natl Acad Sci USA 106(4):1285–1290
Luo Y, Kuo CC, Shen H, Chou J, Greig NH, Hoffer BJ, Wang Y (2009) Delayed treatment with a p53 inhibitor enhances recovery in stroke brain. Ann Neurol 65(5):520–530
Miclescu A, Sharma HS, Martijn C, Wiklund L (2010) Methylene blue protects the cortical blood-brain barrier against ischemia/reperfusion-induced disruptions. Crit Care Med 38(11):2199–2206
Oxenkrug GF (2010) Tryptophan kynurenine metabolism as a common mediator of genetic and environmental impacts in major depressive disorder: the serotonin hypothesis revisited 40 years later. Isr J Psychiatry Relat Sci 47(1):56–63
Pereira LO, Nabinger PM, Strapasson AC, Nardin P, Gonçalves CA, Siqueira IR, Netto CA (2009) Long-term effects of environmental stimulation following hypoxia-ischemia on the oxidative state and BDNF levels in rat hippocampus and frontal cortex. Brain Res 1247:188–195
Rapoport SI (1976) Blood-brain barrier in physiology and medicine. Raven Press, New York
Sharma HS (2005) Pathophysiology of blood-spinal cord barrier in traumatic injury and repair. Curr Pharm Des 11(11):1353–1389 (review)
Sharma HS (2007) Neurotrophic factors in combination: a possible new therapeutic strategy to influence pathophysiology of spinal cord injury and repair mechanisms. Curr Pharm Des 13(18):1841–1874 (review)
Sharma HS (2008) New perspectives for the treatment options in spinal cord injury. Expert Opin Pharmacother 9(16):2773–2800 (review)
Sharma HS (2009) Blood–central nervous system barriers: the gateway to neurodegeneration, neuroprotection and neuroregeneration. In: Lajtha A, Banik N, Ray SK (eds) Handbook of neurochemistry and molecular neurobiology: brain and spinal cord trauma. Springer, Berlin, pp 363–457
Sharma HS, Johanson CE (2007) Intracerebroventricularly administered neurotrophins attenuate blood cerebrospinal fluid barrier breakdown and brain pathology following whole-body hyperthermia: an experimental study in the rat using biochemical and morphological approaches. Ann N Y Acad Sci 1122:112–129
Sharma HS, Kiyatkin EA (2009) Rapid morphological brain abnormalities during acute methamphetamine intoxication in the rat: an experimental study using light and electron microscopy. J Chem Neuroanat 37(1):18–32
Sharma HS, Sharma A (2010) Breakdown of the blood-brain barrier in stress alters cognitive dysfunction and induces brain pathology. New perspective for neuroprotective strategies. In: Ritsner M (ed) Brain protection in schizophrenia, mood and cognitive disorders. Springer, Berlin, pp 243–304
Sharma HS, Westman J (2004) The blood-spinal cord and brain barriers in health and disease. Academic Press, San Diego, pp 1–617
Sharma HS, Ali SF, Dong W, Tian ZR, Patnaik R, Patnaik S, Sharma A, Boman A, Lek P, Seifert E, Lundstedt T (2007a) Drug delivery to the spinal cord tagged with nanowire enhances neuroprotective efficacy and functional recovery following trauma to the rat spinal cord. Ann N Y Acad Sci 1122:197–218
Sharma HS, Sjöquist PO, Ali SF (2007b) Drugs of abuse-induced hyperthermia, blood-brain barrier dysfunction and neurotoxicity: neuroprotective effects of a new antioxidant compound H-290/51. Curr Pharm Des 13(18):1903–1923
Sharma HS, Ali S, Tian ZR, Patnaik R, Patnaik S, Lek P, Sharma A, Lundstedt T (2009) Nano-drug delivery and neuroprotection in spinal cord injury. J Nanosci Nanotechnol 9(8):5014–5037
Westerlund M, Hoffer B, Olson L (2010) Parkinson’s disease: exit toxins, enter genetics. Prog Neurobiol 90(2):146–156 (review)
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Sharma, H.S. Blood–CNS barrier, neurodegeneration and neuroprotection: recent therapeutic advancements and nano-drug delivery. J Neural Transm 118, 3–6 (2011). https://doi.org/10.1007/s00702-010-0542-0
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00702-010-0542-0